79 related articles for article (PubMed ID: 17559623)
21. Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid.
López Roldán A; García Giménez JL; Alpiste Illueca F
PLoS One; 2020; 15(1):e0227757. PubMed ID: 31986169
[TBL] [Abstract][Full Text] [Related]
22. IL-36γ is a pivotal inflammatory player in periodontitis-associated bone loss.
Cloitre A; Halgand B; Sourice S; Caillon J; Huck O; Bugueno IM; Batool F; Guicheux J; Geoffroy V; Lesclous P
Sci Rep; 2019 Dec; 9(1):19257. PubMed ID: 31848404
[TBL] [Abstract][Full Text] [Related]
23. The effect of Phase 1 periodontal treatment on the salivary RANKL/OPG ratio in severe chronic periodontitis.
Ansari Moghadam S; Sarani S; Alijani E; Ansari Moghadam A
Clin Cosmet Investig Dent; 2019; 11():251-257. PubMed ID: 31616190
[TBL] [Abstract][Full Text] [Related]
24. TREM-1 Is Upregulated in Experimental Periodontitis, and Its Blockade Inhibits IL-17A and RANKL Expression and Suppresses Bone loss.
Bostanci N; Abe T; Belibasakis GN; Hajishengallis G
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581596
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis.
Teodorescu AC; Martu I; Teslaru S; Kappenberg-Nitescu DC; Goriuc A; Luchian I; Martu MA; Solomon SM; Mârțu S
J Immunol Res; 2019; 2019():6195258. PubMed ID: 31183390
[TBL] [Abstract][Full Text] [Related]
26. RANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model.
Sojod B; Chateau D; Mueller CG; Babajko S; Berdal A; Lézot F; Castaneda B
Front Physiol; 2017; 8():338. PubMed ID: 28596739
[TBL] [Abstract][Full Text] [Related]
27. Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.
Kanzaki H; Makihira S; Suzuki M; Ishii T; Movila A; Hirschfeld J; Mawardi H; Lin X; Han X; Taubman MA; Kawai T
J Immunol; 2016 Nov; 197(10):3871-3883. PubMed ID: 27815441
[TBL] [Abstract][Full Text] [Related]
28. The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity.
Nakata T; Fujita A; Umeda M; Yoshida H; Inami K; Masuzaki H; Sawai H
Springerplus; 2016; 5():40. PubMed ID: 26835222
[TBL] [Abstract][Full Text] [Related]
29. Effect of hypoxia on the expression of RANKL/OPG in human periodontal ligament cells in vitro.
Yu XJ; Xiao CJ; Du YM; Liu S; Du Y; Li S
Int J Clin Exp Pathol; 2015; 8(10):12929-35. PubMed ID: 26722486
[TBL] [Abstract][Full Text] [Related]
30. Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.
Board-Davies E; Moses R; Sloan A; Stephens P; Davies LC
Stem Cells Transl Med; 2015 Nov; 4(11):1283-93. PubMed ID: 26378260
[TBL] [Abstract][Full Text] [Related]
31. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients.
Hassan SH; El-Refai MI; Ghallab NA; Kasem RF; Shaker OG
Dis Markers; 2015; 2015():341259. PubMed ID: 25814780
[TBL] [Abstract][Full Text] [Related]
32. Expression and regulation of triggering receptor expressed on myeloid cells 1 in periodontal diseases.
Willi M; Belibasakis GN; Bostanci N
Clin Exp Immunol; 2014 Oct; 178(1):190-200. PubMed ID: 24924298
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory and bone remodeling responses to the cytolethal distending toxins.
Belibasakis GN; Bostanci N
Cells; 2014 Apr; 3(2):236-46. PubMed ID: 24709959
[TBL] [Abstract][Full Text] [Related]
34. Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.
Kraus D; Jäger A; Abuduwali N; Deschner J; Lossdörfer S
Clin Oral Investig; 2012 Apr; 16(2):611-8. PubMed ID: 22186940
[TBL] [Abstract][Full Text] [Related]
35. Porphyromonas gingivalis induces RANKL in T-cells.
Belibasakis GN; Reddi D; Bostanci N
Inflammation; 2011 Apr; 34(2):133-8. PubMed ID: 20446027
[TBL] [Abstract][Full Text] [Related]
36. RANKL and OPG mRNA level after non-surgical periodontal treatment.
Dereka XE; Markopoulou CE; Fanourakis G; Tseleni-Balafouta S; Vrotsos IA
Inflammation; 2010 Jun; 33(3):200-6. PubMed ID: 20033478
[TBL] [Abstract][Full Text] [Related]
37. Expression and regulation of the NALP3 inflammasome complex in periodontal diseases.
Bostanci N; Emingil G; Saygan B; Turkoglu O; Atilla G; Curtis MA; Belibasakis GN
Clin Exp Immunol; 2009 Sep; 157(3):415-22. PubMed ID: 19664151
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
[TBL] [Abstract][Full Text] [Related]
39. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
40. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
